Form 4 Filing for Corcept Therapeutics Inc.

This filing details transactions by Roberto Wandenkolk Vieira, President of Oncology at Corcept Therapeutics Inc. On October 2, 2026, Vieira acquired 8,333 shares of Common Stock through the exercise of a stock option at a price of $0.00 per share, increasing his post-transaction shares to 133,334. The same day, Vieira sold 1,100 shares at a weighted average price of $114.52, 2,086 shares at $115.73, and 5,147 shares at $116.59. These sales were executed under a pre-existing 10b5-1 plan. The filing also notes that some reported shares are subject to vesting conditions tied to restricted stock awards and stock options.